Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Abnormal blood test results during treatment with asciminibDuring treatment with asciminib, blood test results may become abnormal, which helps your doctor assess your organ functi···【more】
Article source：Captain MedicineRelease date：2026-04-24Recommended：19
What to do if you miss a dose of asciminib or take an overdoseIf you forget to take your medicine: For the once-daily regimen, if it is less than 12 hours until your next scheduled···【more】
Article source：Captain MedicineRelease date：2026-04-24Recommended：20
Interactions of asciminib with other medicines and foodDuring treatment with asciminib, special attention should be paid to certain medicines that may affect its efficacy or increa···【more】
Article source：Captain MedicineRelease date：2026-04-24Recommended：20
What is asciminib and what is it used for?Asciminib is an anticancer medicine containing the active substance asciminib. It belongs to a class of medicines called protein kinase in···【more】
Article source：Captain MedicineRelease date：2026-04-24Recommended：21
What is asciminib and what is it used forAsciminib is an anticancer medicine containing the active substance asciminib. It belongs to a class of medicines called protein kinase inh···【more】
Article source：Captain MedicineRelease date：2026-04-24Recommended：20
Common Side Effects of AdagrasibIn clinical trials, the most common side effects of Adagrasib (incidence >20%) primarily include gastrointestinal reactions and systemic symptoms···【more】
Article source：Captain MedicineRelease date：2026-04-22Recommended：23
Is Adagrasib effective in treating?The pivotal study supporting the approval of Adagrasib is a multicenter, single-arm Phase II trial that enrolled 116 adult patients with KRASG12C···【more】
Article source：Captain MedicineRelease date：2026-04-22Recommended：21
How to use Adagrasib?Adagrasib is an oral tablet. The recommended dosage is twice daily with a fixed dose, approximately 12 hours apart between the two doses. Patients should swall···【more】
Article source：Captain MedicineRelease date：2026-04-22Recommended：31
Mechanism of Action of AdagrasibSpecific alterations in the KRAS gene produce an abnormally structured KRAS protein that remains persistently activated, continuously transmitting p···【more】
Article source：Captain MedicineRelease date：2026-04-22Recommended：30
How to Take Adagrasib Correctly?Standard Dosage:The recommended dosage is 600 mg (three 200 mg tablets) taken twice daily, approximately every 12 hours, at the same times each day.···【more】
Article source：Captain MedicineRelease date：2026-04-21Recommended：30
Serious Side Effects Requiring Immediate Medical AttentionAdagrasib may cause the following serious side effects, some of which may be life-threatening:1. Gastrointestinal problems···【more】
Article source：Captain MedicineRelease date：2026-04-21Recommended：27
Precautions Before Taking AdagrasibBefore starting Adagrasib, be sure to tell your healthcare team about all of your medical history, especially the following conditions:Heart prob···【more】
Article source：Captain MedicineRelease date：2026-04-21Recommended：33
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：2612025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：4822024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：2672025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：2762025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：2572025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：3022025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：2632025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：2432025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
